Press Releases

  • All
  • 2009
  • 2010
  • 2011
  • 2012
  • 2014
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022

 Athens, 15 November 2022: Tikun Europe, the leading pharmaceutical company in research, development and production of medical cannabis products in Greece, and the Greek pharmaceutical group Lavipharm are entering into a strategic partnership for the distribution of Tikun’s new products, which are anticipated to be...

Peania, 10 November 2022 - Lavipharm once again participated in CPhI Worldwide 2022, the largest exhibition in the pharmaceutical industry worldwide and the meeting point for thousands of pharma professionals from all over the globe. The live exhibition took place from 1 to...

Peania, 12 October 2022 – Lavipharm is releasing a new tadalafil pharmaceutical product on the Greek market indicated for the treatment of erectile dysfunction, as well as of the symptoms of benign prostatic hyperplasia in adult men. This new product further enhances Lavipharm’s long-standing, dynamic...

Peania, 30 August 2022 – The Extraordinary Shareholders’ Meeting of Lavipharm S.A. took place today, Tuesday, 30 August 2022, at the corporate headquarters in Peania and decided to Increase its Share Capital by up to EUR 58 million, with cash payments and pre-emption rights for existing...

Peania, 30 June 2022 – Lavipharm S.A. held its Annual Shareholders' Meeting today at its corporate headquarters in Peania. The Meeting took place with the necessary quorum, with 61.79% of shareholders in attendance. Lavipharm's Chairman Minas Tanes welcomed the participants noting that “We are very satisfied with...

«Lavipharm SA, in compliance with the requirement under Article 4.1.4.3.1 of the Athens Stock Exchange Rulebook, hereby releases its Financial Calendar for the year 2022 : Announcement of the 2021 Annual Financial Accounts: Monday, March 21st, 2022 Analysts’ FY 2021 conference call : Friday, April...

Paiania, January 18, 2022 - Lavipharm SA, in the context of its obligations in accordance with the provisions of Law 4706/2020 on Corporate Governance and the decision No. 3/347/12.07.2005 of the Hellenic Capital Market Commission’s Board of Directors, informs the investors’ community that, following the...